Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/30468
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 16999/19305 (88%)
造访人次 : 9861452      在线人数 : 1620
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.cnu.edu.tw/handle/310902800/30468


    標題: IS HMGA2 a Cancer Therapeutics Target?
    作者: Angela Y.J. Li
    LeeMing Boo
    Shih-Ya Wang
    Xu Li
    H.Helen Lin
    Xiuzhu Sun
    ClayC.C. Wang
    Yun Yen
    Benjamin P.C. Chen
    David J. Chen
    David K. Ann
    貢獻者: Departhment of Clinical and Molecular Pharmacology, City of Hope National Medical Center
    Department of Pharmacology and Pharmaceutical Sciences,University of Southern California
    Division of Molecular Radiation Biology,Department oh Radiation Oncology,University of Texas Southwestern Medical Center
    日期: 2008-07
    上傳時間: 2017-12-04 15:50:51 (UTC+8)
    摘要: HMGA2 is located on chromosome 12q14.3, which is frequently amplified or subjected to chromosomalrearrangements found in human cancers. However, the detailed mechanismunderlying the HMGA2-dysregulated DNA damage response remains unclear. Herein we provide the first molecular and cellular evidence to suggest the direct involvement of HMGA2 in causing defects in NHEJ repair against DNA double-strand breaks (DSBs).Second, expression of HMGA2 results in spontaneous chromosome aberrations in WI-38 cells. Third, using real-time imaging in living cells,a sustained accumulation of DNA-PKcs at DSB sites in HMGA2-expressing cells receiving microirradiation was observed, resembling to observations found among DNA-PKcs mutants. In addition,HMGA2 significantly decreased overall HDAC activities, enhanced basal telomerase activities,and conveyed resistance to two different classes of telomerase inhibitors,TMPyP4,a G-quadruplex stabilizer,and GRN163L,an oligonucleotide targeting the active site in the template region of telomerase RNA (hTR), using telomeric repeat amplification protocol(TRAP)assays. Expression of HMGA2 rendered co-transfected hTERT-reporter activation in a dose-dependent manner in WI-38 cells. Moreover, observations on the reactivation of telomerase activity in non-transformed WI-38 cells transduced with lenti-HMGA2 and a positive correlation between the expression levels of HMGA2 and hTERT(p=0.01)from34 breast cancer patient samples further confirm a critical role for HMGA2 to induce hTERT expression .Lastly, increased HMGA2 expression correlates with unfavorable treatment outcome in breast cancer. Taken together, these results support a model in which the interplay between Ku70/80and HMGA2 interferes with NHEJ and telomere shortening and shed light on a novel role of HMGA2 in promoting genome instability. Clinically, the elevated expression of HMGA2 in a broad spectrum of cancers can be potentially utilized as a biomarker that reflects a lack of proper DNA damage response and telomere homeostasis and suggest a potential cancer therapeutics marker.
    显示于类别:[藥理學院] 2008第五屆海峽化學、生物及材料研討會

    文件中的档案:

    档案 描述 大小格式浏览次数
    A1.pdf449KbAdobe PDF50检视/开启


    在CNU IR中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈